Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy

Medical Physics

Volumn 37, Issue 4, 2010, Pages 1533-1544

  Avanzo, Michele ^a   Stancanello, Joseph ^b   Franchin, Giovanni ^a   Sartor, Giovanna ^a   Jena, Rajesh ^c   Drigo, Annalisa ^a   Dassie, Andrea ^a   Gigante, Marco ^a   Capra, Elvira ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b SIEMENS AG   (Germany)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chemoradiation; Hypoxia; Intensity modulated; Nasopharyngeal carcinoma; Tumor control probability

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; FADING (RADIO); PATIENT MONITORING; RADIATION EFFECTS; RADIOTHERAPY; TRANSMISSION CONTROL PROTOCOL; TUMORS; UNCERTAINTY ANALYSIS;

CHEMO RADIATIONS; HYPOXIA; INTENSITY-MODULATED; NASOPHARYNGEAL CARCINOMA; TUMOR CONTROL PROBABILITY;

SENSITIVITY ANALYSIS;

EID: 77950557341     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3352832     Document Type: Article

References (62)

1. W. I. Wei and J. S. Sham, " Nasopharyngeal carcinoma.," Lancet 0140-6736 365 (9476), 2041-2054 (2005). 10.1016/S0140-6736(05)66698-6 (Pubitemid 40812341)
2. C. A. Perez, V. R. Devineni, V. Marcial-Vega, J. E. Marks, J. R. Simpson, and N. Kucik, " Carcinoma of the nasopharynx: Factors affecting prognosis.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 23 (2), 271-280 (1992).
3. A. W. Lee, D. K. Chan, J. F. Fowler, Y. F. Poon, W. Foo, S. C. Law, S. K. O, S. Y. Tung, and R. Chappell, " Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma.," Radiother. Oncol. 0167-8140 36 (1), 24-31 (1995). 10.1016/0167-8140(95)01579-6
4. 2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 35 (3), 463-469 (1996). 10.1016/S0360-3016(96)80007-1 (Pubitemid 126745218)
5. M. Al-Sarraf, M. LeBlanc, P. G. Giri, K. K. Fu, J. Cooper, T. Vuong, A. A. Forastiere, G. Adams, W. A. Sakr, D. E. Schuller, and J. F. Ensley, " Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099.," J. Clin. Oncol. 0732-183X 16 (4), 1310-1317 (1998). (Pubitemid 28175745)
6. J. C. Lin, J. S. Jan, C. Y. Hsu, W. M. Liang, R. S. Jiang, and W. Y. Wang, " Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival.," J. Clin. Oncol. 0732-183X 21 (4), 631-637 (2003). 10.1200/JCO.2003.06.158 (Pubitemid 46621896)
7. S. A. Yeh, Y. Tang, C. C. Lui, Y. J. Huang, and E. Y. Huang, " Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 62 (3), 672-679 (2005). 10.1016/j.ijrobp.2004.11.002 (Pubitemid 40779753)
8. J. Wee, " Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.," J. Clin. Oncol. 0732-183X 23 (27), 6730-6738 (2005). 10.1200/JCO.2005.16.790 (Pubitemid 46190268)
9. D. L. W. Kwong, J. S. T. Sham, L. H. T. Leung, A. C. K. Cheng, W. M. Ng, P. W. K. Kwong, W. M. Lui, C. C. Yau, P. M. Wu, W. Wei, and G. Au, " Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 64 (2), 374-381 (2006). (Pubitemid 43083421)
10. Y. Chen, M. Z. Liu, S. B. Liang, J. F. Zong, Y. P. Mao, L. L. Tang, Y. Guo, A. H. Lin, X. F. Zeng, and J. Ma, " Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 71 (5), 1356-1364 (2008). 10.1016/j.ijrobp.2007.12.028
11. A. Al-Amro, N. Al-Rajhi, Y. Khafaga, M. Memon, A. Al-Hebshi, A. El-Enbabi, G. El-Husseiny, A. Radawi, A. Belal, A. Allam, and M. El-Sebaie, " Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 62 (2), 508-513 (2005). 10.1016/j.ijrobp.2004.09.050 (Pubitemid 40704469)
12. D. L. Kwong, J. S. Sham, D. T. Chua, D. T. Choy, G. K. Au, and P. M. Wu, " The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 39 (3), 703-710 (1997). 10.1016/S0360-3016(97)00339-8 (Pubitemid 27441440)
13. J. Bussink, J. H. Kaanders, and A. J. van der Kogel, " Tumor hypoxia at the micro-regional level: Clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.," Radiother. Oncol. 0167-8140 67 (1), 3-15 (2003). 10.1016/S0167-8140(03)00011-2 (Pubitemid 36575463)
14. L. Xueguan, W. Xiaoshen, Z. Yongsheng, H. Chaosu, S. Chunying, and F. Yan, " Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide.," Clin. Oncol. (R Coll. Radiol) 0936-6555 20 (8), 606-612 (2008). 10.1016/j.clon.2008.07.001
15. E. P. Hui, A. T. Chan, F. Pezzella, H. Turley, K. F. To, T. C. Poon, B. Zee, F. Mo, P. M. Teo, D. P. Huang, K. C. Gatter, P. J. Johnson, and A. L. Harris, " Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.," Clin. Cancer Res. 1078-0432 8 (8), 2595-2604 (2002). (Pubitemid 34856346)
16. S. H. Yeh, R. S. Liu, L. C. Wu, D. J. Yang, S. H. Yen, C. W. Chang, T. W. Yu, K. L. Chou, and K. Y. Chen, " Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.," Eur. J. Nucl. Med. 0340-6997 23 (10), 1378-1383 (1996). 10.1007/BF01367595 (Pubitemid 26340592)
17. S. B. Reddy and S. K. Williamson, " Tirapazamine: A novel agent targeting hypoxic tumor cells.," Expert Opin. Investig. Drugs 18 (1), 77-87 (2009). 10.1517/13543780802567250 1354-3784
18. T. R. Mackie, " History of tomotherapy.," Phys. Med. Biol. 0031-9155 51 (13), R427-R453 (2006). 10.1088/0031-9155/51/13/R24 (Pubitemid 43958627)
19. J. F. Fowler, " The linear-quadratic formula and progress in fractionated radiotherapy.," Br. J. Radiol. 0007-1285 62 (740), 679-694 (1989). 10.1259/0007-1285-62-740-679
20. S. Webb and A. E. Nahum, " A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.," Phys. Med. Biol. 0031-9155 38 (6), 653-666 (1993). 10.1088/0031-9155/38/6/001 (Pubitemid 23188329)
21. T. R. Munro and C. W. Gilbert, " The relation between tumour lethal doses and the radiosensitivity of tumour cells.," Br. J. Radiol. 0007-1285 34, 246-251 (1961). 10.1259/0007-1285-34-400-246
22. A. E. Nahum, B. Movsas, E. M. Horwitz, C. C. Stobbe, and J. D. Chapman, " Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 57 (2), 391-401 (2003). 10.1016/S0360-3016(03)00534-0 (Pubitemid 37040935)
23. R. M. Wyatt, A. H. Beddoe, and R. G. Dale, " The effects of delays in radiotherapy treatment on tumour control.," Phys. Med. Biol. 0031-9155 48 (2), 139-155 (2003). 10.1088/0031-9155/48/2/301 (Pubitemid 36204153)
24. B. Jones and R. G. Dale, " The potential for mathematical modeling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy.," Br. J. Radiol. 0007-1285 78 (934), 939-944 (2005). 10.1259/bjr/40226390 (Pubitemid 41582246)
25. G. G. Steel, " The search for therapeutic gain in the combination of radiotherapy and chemotherapy.," Radiother. Oncol. 0167-8140 11 (1), 31-53 (1988). 10.1016/0167-8140(88)90044-8
26. J. Ma, H. Q. Mai, M. H. Hong, H. Q. Min, Z. D. Mao, N. J. Cui, T. X. Lu, and H. Y. Mo, " Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.," J. Clin. Oncol. 0732-183X 19 (5), 1350-1357 (2001). (Pubitemid 32202540)
27. D. T. Chua, J. Ma, J. S. Sham, H. Q. Mai, D. T. Choy, M. H. Hong, T. X. Lu, G. K. Au, and H. Q. Min, " Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 65 (5), 1300-1306 (2006). 10.1016/j.ijrobp.2006.02.016 (Pubitemid 44425202)
28. D. J. Carlson, R. D. Stewart, and V. A. Semenenko, " Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.," Med. Phys. 0094-2405 33 (9), 3105-3115 (2006). 10.1118/1.2229427 (Pubitemid 44327410)
29. M. C. Carlone, B. Warkentin, P. Stavrev, and B. G. Fallone, " Fundamental form of a population TCP model in the limit of large heterogeneity.," Med. Phys. 0094-2405 33 (6), 1634-1642 (2006). 10.1118/1.2193690 (Pubitemid 43830252)
30. H. R. Withers, J. M. Taylor, and B. Maciejewski, " The hazard of accelerated tumor clonogen repopulation during radiotherapy.," Acta Oncol. 0284-186X 27 (2), 131-146 (1988). 10.3109/02841868809090333
31. S. A. Roberts and J. H. Hendry, " The delay before onset of accelerated tumour cell repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection of worldwide tumour-control data.," Radiother. Oncol. 0167-8140 29 (1), 69-74 (1993). 10.1016/0167-8140(93)90175-8 (Pubitemid 23336821)
32. S. Webb, " Optimum parameters in a model for tumour control probability including interpatient heterogeneity.," Phys. Med. Biol. 0031-9155 39 (11), 1895-1914 (1994). 10.1088/0031-9155/39/11/007 (Pubitemid 24342691)
33. J. F. Fowler, " Is there an optimum overall time for head and neck radiotherapy? A review, with new modeling.," Clin. Oncol. (R Coll. Radiol) 0936-6555 19 (1), 8-22 (2007). 10.1016/j.clon.2006.09.008 (Pubitemid 46044065)
34. J. F. Fowler, " Optimum overall times II: Extended modeling for head and neck radiotherapy.," Clin. Oncol. (R Coll. Radiol) 0936-6555 20 (2), 113-126 (2008). 10.1016/j.clon.2007.11.003
35. P. Okunieff, J. de Bie, E. P. Dunphy, D. J. Terris, and M. Hockel, " Oxygen distributions partly explain the radiation response of human squamous cell carcinomas.," Br. J. Cancer Suppl. 0306-9443 27, S185-S190 (1996). (Pubitemid 26237958)
36. S. Marchal, C. Marchal, R. M. Parache, N. Benjaafar, M. Odda, A. Leclerc, J. L. Merlin, B. el Gueddarri, and P. Bey, " Combined flow cytometry and immunohistochemistry analyses for the assessment of nasopharyngeal carcinoma cell kinetics by in vivo bromodeoxyuridine infusion.," Cytometry 0196-4763 29 (2), 165-172 (1997). 10.1002/(SICI)1097-0320(19971001)29:2<165::AID- CYTO9>3.0.CO;2-C (Pubitemid 27444666)
37. F. Zolzer and C. Streffer, " Increased radiosensitivity with chronic hypoxia in four human tumor cell lines.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 54 (3), 910-920 (2002). 10.1016/S0360-3016(02)02963-2
38. E. P. Hui, T. C. Poon, P. M. Teo, F. Mo, B. Zee, S. F. Leung, S. Ho, T. S. Mok, W. H. Kwan, P. J. Johnson, and A. T. Chan, " A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.," Radiother. Oncol. 0167-8140 69 (1), 53-62 (2003). 10.1016/S0167-8140(03)00248-2 (Pubitemid 37346189)
39. M. C. H. Lee, A. W. M. Lee, Y. H. Ling, E. Pang, W. T. Ng, A. W. M. Hung, S. K. C. Leung, D. W. I. Chan, A. L. Y. Law, and T. K. Yau, " 2373: Fitting of biological parameters for tumor control probability of nasopharyngeal carcinoma.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 66 (3), S417-S418 (2006). 10.1016/j.ijrobp.2006.07.782
40. J. F. Fowler, " Correction to Kasibhatla How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int J Radiat Oncol Biol Phys 2007;68:1491-1495).
41. Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 71 (2), 326-329 (2008). 10.1016/j.ijrobp.2008.01.052 (Pubitemid 351636201)
42. E. Sham and R. E. Durand, " Repopulation characteristics and cell kinetic parameters resulting from multi-fraction irradiation of xenograft tumors in SCID mice.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 43 (3), 617-622 (1999). 10.1016/S0360-3016(98)00427-1 (Pubitemid 29107185)
43. P. M. Teo, S. F. Leung, W. Y. Lee, and B. Zee, " Intracavitary brachytherapy significantly enhances local control of early T -stage nasopharyngeal carcinoma: The existence of a dose-tumor-control relationship above conventional tumoricidal dose.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 46 (2), 445-458 (2000). 10.1016/S0360-3016(99)00326-0 (Pubitemid 30067796)
44. C. M. Chan, B. B. Ma, E. P. Hui, S. C. Wong, F. K. Mo, S. F. Leung, M. K. Kam, and A. T. Chan, " Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma-A prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor.," Oral Oncol. 0964-1955 43 (4), 373-378 (2007). 10.1016/j.oraloncology.2006.04.004 (Pubitemid 46415794)
45. T. Tanaka, T. Furukawa, S. Fujieda, S. Kasamatsu, Y. Yonekura, and Y. Fujibayashi, " Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models.," Nucl. Med. Biol. 0969-8051 33 (6), 743-750 (2006). 10.1016/j.nucmedbio.2006.05.005 (Pubitemid 44247730)
46. B. Jones and R. G. Dale, " Estimation of tumour hypoxic fraction from clinical data sets compatible with accelerated repopulation.," Acta Oncol. 0284-186X 37 (3), 263-268 (1998). 10.1080/028418698429568 (Pubitemid 28307851)
47. J. Zádor, I. G. Zsely, T. Turanyi, M. Ratto, S. Tarantola, and A. Saltelli, " Local and global uncertainty analyses of a methane flame model.," J. Phys. Chem. A 1089-5639 109 (43), 9795-9807 (2005). 10.1021/jp053270i (Pubitemid 41609707)
48. International Commission on Radiation Units and Measurements, " Prescribing, recording, and reporting photon beam therapy.," Report No. 50 (International Commission on Radiation Units and Measurements, Bethesda, MD, 1993).
49. K. Kim, H. G. Wu, H. J. Kim, M. W. Sung, K. H. Kim, S. H. Lee, D. S. Heo, H. J. Kim, and C. Park II, " Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.," Head Neck 1043-3074 31 (9), 1121-1128 (2009). 10.1002/hed.21076
50. G. Franchin, E. Vaccher, R. Talamini, C. Gobitti, E. Minatel, D. Politi, G. Sartor, M. G. Trovo, and L. Barzan, " Nasopharyngeal cancer WHO type II-III: Monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy.," Oral Oncol. 0964-1955 38 (2), 137-144 (2002). 10.1016/S1368-8375(01)00034-3 (Pubitemid 34168196)
51. J. B. Vermorken, E. Remenar, C. van Herpen, T. Gorlia, R. Mesia, M. Degardin, J. S. Stewart, S. Jelic, J. Betka, J. H. Preiss, D. van den Weyngaert, A. Awada, D. Cupissol, H. R. Kienzer, A. Rey, I. Desaunois, J. Bernier, J. L. Lefebvre, and EORTC 24971/TAX 323 Study Group, " Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.," N. Engl. J. Med. 0028-4793 357 (17), 1695-1704 (2007). 10.1056/NEJMoa071028 (Pubitemid 350005151)
52. Y. Kim and W. A. Tome, " Risk-adaptive optimization: Selective boosting of high-risk tumor subvolumes.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 66 (5), 1528-1542 (2006). 10.1016/j.ijrobp.2006.08.032
53. K. Slosarek, A. Zajusz, and M. Szlag, " Comparison of traditional and simultaneous IMRT boost technique basing on therapeutic gain calculation.," Med. Dosim. 0739-0211 33 (4), 299-302 (2008). 10.1016/j.meddos.2008.02.001
54. B. Warkentin, P. Stavrev, N. A. Stavreva, and B. G. Fallone, " Limitations of a TCP model incorporating population heterogeneity.," Phys. Med. Biol. 0031-9155 50 (15), 3571-3588 (2005). 10.1088/0031-9155/50/15/006 (Pubitemid 41019097)
55. P. M. Wu, D. T. Chua, J. S. Sham, L. Leung, D. L. Kwong, M. Lo, A. Yung, and D. T. Choy, " Tumor control probability of nasopharyngeal carcinoma: A comparison of different mathematical models.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 37 (4), 913-920 (1997). 10.1016/S0360-3016(96)00588-3 (Pubitemid 27181326)
56. S. Webb and A. Nahum, " Regarding, Wu, Chua, Sham, IJROBP 37(4), 913-920 (1997).," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 40 (4), 1009-1010 (1998). 10.1016/S0360-3016(97)00944-9 (Pubitemid 28150824)
57. P. Stadler, A. Becker, H. J. Feldmann, G. Hansgen, J. Dunst, F. Wurschmidt, and M. Molls, " Influence of the hypoxic subvolume on the survival of patients with head and neck cancer.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 44 (4), 749-754 (1999). 10.1016/S0360-3016(99)00115-7 (Pubitemid 29284123)
58. M. Nordsmark, M. Overgaard, and J. Overgaard, " Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.," Radiother. Oncol. 0167-8140 41 (1), 31-39 (1996). 10.1016/S0167-8140(96)91811-3 (Pubitemid 26396294)
59. B. Baujat, H. Audry, J. Bourhis, A. T. Chan, H. Onat, D. T. Chua, D. L. Kwong, M. Al-Sarraf, K. H. Chi, M. Hareyama, S. F. Leung, K. Thephamongkhol, J. P. Pignon, and MAC-NPC Collaborative Group, " Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 64 (1), 47-56 (2006). 10.1016/j.ijrobp.2005.06.037 (Pubitemid 41831208)
60. J. A. Langendijk, C. R. Leemans, J. Buter, J. Berkhof, and B. J. Slotman, " The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature.," J. Clin. Oncol. 0732-183X 22 (22), 4604-4612 (2004). 10.1200/JCO.2004.10.074 (Pubitemid 41185128)
61. J. Z. Wang, N. A. Mayr, X. A. Li, and R. D. Stewart, " Modeling prostate cancer: In regards to Nahum [Int. J. Radiat. Oncol., Biol., Phys. 57, 391-401 (2003)].
62. Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 61 (1), 309-310 (2005). 10.1016/j.ijrobp.2004.08.043 (Pubitemid 40039141)